During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga’s extensive database of analyst ratings, including by analyst accuracy.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.

Getty Realty Corp (NYSE:GTY)

  • Dividend Yield: 5.85%
  • RBC Capital analyst Brad Heffern maintained a Sector Perform rating and raised the price target from $35 to $36 on July 24, 2026. This analyst has an accuracy rate of 54%.
  • Citizens analyst Mitch Germain maintained a Market Outperform rating and raised the price target from $35 to $39 on July 23, 2026. This analyst has an accuracy rate of 55%.
  • Recent News: On July 22, Getty Realty posted downbeat quarterly results.
  • Benzinga Pro’s real-time newsfeed alerted to latest GTY news.

Healthpeak Properties, Inc (NYSE:DOC)

  • Dividend Yield: 5.87%
  • Citigroup analyst Nick Joseph maintained a Neutral rating and raised the price target from $20 to $22 on Aug. 11, 2026. This analyst has an accuracy rate of 55%.
  • RBC Capital analyst Michael Carroll maintained an Outperform rating and increased the price target from $21 to $24 on Aug. 10, 2026. This analyst has an accuracy rate of 63%.
  • Recent News: On Aug. 4, Healthpeak Properties reported better-than-expected second-quarter financial results and raised its FY26 FFO guidance with its midpoint above estimates.
  • Benzinga Pro’s real-time newsfeed alerted to latest DOC news

Omega Healthcare Investors, Inc (NYSE:OHI)

  • Dividend Yield: 5.78%
  • Citigroup analyst Nick Joseph maintained a Buy rating and raised the price target from $52 to $58 on Aug. 4, 2026. This analyst has an accuracy rate of 55%.
  • Cantor Fitzgerald analyst Richard Anderson maintained an Overweight rating and increased the price target from $52 to $56 on July 31, 2026. This analyst has an accuracy rate of 63%
  • Recent News: On July 29, Omega Healthcare posted upbeat quarterly results.
  • Benzinga Pro’s real-time newsfeed alerted to latest OHI news

Photo via Shutterstock